Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R C Carlisle

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
The Pharos of Alpha Omega Alpha-Honor Medical Society. Alpha Omega Alpha|March 22, 2001
Hellen Taussig--a heroineR C Carlisle
Science (New York, N.Y.)|February 12, 1988
The meadowcroft rockshelterJ M Adovasio, R C Carlisle
Gene Therapy|June 15, 2001
Triggered intracellular activation of disulfide crosslinked polyelectrolyte gene delivery complexes with extended systemic circulation in vivoD Oupický, R C Carlisle, L W Seymour
Clinical and Experimental Immunology|April 10, 2019
Novel approaches for the design, delivery and administration of vaccine technologiesJ Wallis, D P Shenton, R C Carlisle
The Journal of Biological Chemistry|October 16, 2001
Melittin enables efficient vesicular escape and enhanced nuclear access of nonviral gene delivery vectorsM Ogris, R C Carlisle, T Bettinger, et al.
Gene Therapy|February 22, 2008
Factors influencing retention of adenovirus within tumours following direct intratumoural injectionM Bazan-Peregrino, R C Carlisle, L Purdie, et al.
Nucleic Acids Research|September 15, 2001
Peptide-mediated RNA delivery: a novel approach for enhanced transfection of primary and post-mitotic cellsT Bettinger, R C Carlisle, M L Read, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 16, 2001
Adenovirus hexon protein enhances nuclear delivery and increases transgene expression of polyethylenimine/plasmid DNA vectorsR C Carlisle, T Bettinger, M Ogris, et al.
Gene Therapy|July 1, 2006
Use of synthetic vectors for neutralising antibody resistant delivery of replicating adenovirus DNAR C Carlisle, S S Briggs, A B Hale, et al.
Human Gene Therapy|August 20, 2008
Comparison of molecular strategies for breast cancer virotherapy using oncolytic adenovirusM Bazan-Peregrino, R C Carlisle, R Hernandez-Alcoceba, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The Pharos of Alpha Omega Alpha-Honor Medical Society. Alpha Omega Alpha|March 22, 2001
Hellen Taussig--a heroineR C Carlisle
Science (New York, N.Y.)|February 12, 1988
The meadowcroft rockshelterJ M Adovasio, R C Carlisle
Gene Therapy|June 15, 2001
Triggered intracellular activation of disulfide crosslinked polyelectrolyte gene delivery complexes with extended systemic circulation in vivoD Oupický, R C Carlisle, L W Seymour
Clinical and Experimental Immunology|April 10, 2019
Novel approaches for the design, delivery and administration of vaccine technologiesJ Wallis, D P Shenton, R C Carlisle
The Journal of Biological Chemistry|October 16, 2001
Melittin enables efficient vesicular escape and enhanced nuclear access of nonviral gene delivery vectorsM Ogris, R C Carlisle, T Bettinger, et al.
Gene Therapy|February 22, 2008
Factors influencing retention of adenovirus within tumours following direct intratumoural injectionM Bazan-Peregrino, R C Carlisle, L Purdie, et al.
Nucleic Acids Research|September 15, 2001
Peptide-mediated RNA delivery: a novel approach for enhanced transfection of primary and post-mitotic cellsT Bettinger, R C Carlisle, M L Read, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 16, 2001
Adenovirus hexon protein enhances nuclear delivery and increases transgene expression of polyethylenimine/plasmid DNA vectorsR C Carlisle, T Bettinger, M Ogris, et al.
Gene Therapy|July 1, 2006
Use of synthetic vectors for neutralising antibody resistant delivery of replicating adenovirus DNAR C Carlisle, S S Briggs, A B Hale, et al.
Human Gene Therapy|August 20, 2008
Comparison of molecular strategies for breast cancer virotherapy using oncolytic adenovirusM Bazan-Peregrino, R C Carlisle, R Hernandez-Alcoceba, et al.
Pageof 2